-
Technologies
Themes / Divisions
Sections on this page

Publications

Selected publications from Dr Charlotte Slade

Chan S, Morgan B, Yong MK, Margetts M, Farchione AJ, Lucas EC, Godsell J, Giang NA, Slade CA, von Borstel A, Bryant VL, Howson LJ. Cytomegalovirus drives Vδ1+ γδ T cell expansion and clonality in common variable immunodeficiency. Nature Communications. 2024;15(1):10.1038/s41467-024-48527-3

Zhou JJ, Jin C, Leang ZX, Chatelier J, Godsell J, Tsang S, Douglass JA, Yong MK, Slavin M, Bryant VL, Slade CA, Chan S. A single-center experience of COVID-19 infection in patients with primary immunodeficiency. Journal of Allergy and Clinical Immunology Global. 2024;3(2):10.1016/j.jacig.2024.100241

Cocks B, Gail E, Green S, Bryant V, Slade C, Tang M, Cole T, Douglass J. 55 Diagnostic utility of the whole blood transcriptome and mucosal microbiome alterations in patients with primary immunodeficiency. Clinical Immunology. 2024;262:10.1016/j.clim.2024.109997

Aiuti A, Al-Muhsen S, Al-Mulla F, Andreakos E, Arias AA, Feldman HB, Bastard P, Bondarenko A, Borghesi A, Bousfiha AA, Brodin P, Bryceson Y, Casari G, Christodoulou J, Colobran R, Condino-Neto A, Fellay J, Flores C, Franco JL, Haerynck F, Halwani R, Hammarström L, Heath JR, Hsieh EWY, Itan Y, Kaja E, Kisand K, Ku C-L, Ling Y, Lau Y-L, Mansouri D, Meyts I, Milner JD, Mogensen TH, Novelli A, Novelli G, Okamoto K, Ozcelik T, de Diego RP, Perez-Tur J, Perlin DS, Prando C, Pujol A, Quintana-Murci L, Renia L, Resnick I, Rodríguez-Gallego C, Sancho-Shimizu V, Sediva A, Seppänen MRJ, Shahrooei M, Shcherbina A, Palacín PS, Pesole G, Spaan AN, Su HC, Tancevski I, Tayoun AA, Amara A, Gorochov G, Temel ŞG, Thorball C, Tiberghien P, Trouillet-Assant S, Turvey S, Uddin KMF, Uddin MJ, van de Beek D, Vidigal M, Vinh DC, von Bernuth H, Wauters J, Zatz M, Zhang S-Y, Ng LFP. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency. Nature. 2023;623(7988):10.1038/s41586-023-06717-x

Garnish SE, Martin KR, Kauppi M, Jackson VE, Ambrose R, Eng VV, Chiou S, Meng Y, Frank D, Tovey Crutchfield EC, Patel KM, Jacobsen AV, Atkin-Smith GK, Di Rago L, Doerflinger M, Horne CR, Hall C, Young SN, Cook M, Athanasopoulos V, Vinuesa CG, Lawlor KE, Wicks IP, Ebert G, Ng AP, Slade CA, Pearson JS, Samson AL, Silke J, Murphy JM, Hildebrand JM. A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation. Nature Communications. 2023;14(1):10.1038/s41467-023-41724-6

McComish JS, Slade CA, Buizen L, Paul SK, Chatelier JW, Unglik G, Nicholls KA, Spriggs K, Chan SS, Godsell J, Auyeung P, Tan ZH, DeLuca J, Patel M, Kuek LE, Tran Y, Kern JS, Scardamaglia L, Varigos GA, Juneja S, Grabek JA, Christie M, Mackay GA, Douglass JA. Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM). The Journal of Allergy and Clinical Immunology In Practice. 2023;11(7):10.1016/j.jaip.2023.04.008

Mendivil J, DerSarkissian M, Banerji A, Diwakar L, Katelaris CH, Keith PK, Kim H, Lacuesta G, Magerl M, Slade C, Smith WB, Choudhry Z, Simon A, Sarda SP, Busse PJ. A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis. Allergy, Asthma & Clinical Immunology. 2023;19(1):10.1186/s13223-023-00795-2

Gail E, Green S, Bryant V, Slade C, Tang M, Cole T, Cocks B, Douglass J. Identifying patients with primary immunodeficiency using statistical modelling of unique genetic signatures from transcriptomic data. Clinical Immunology. 2023;250:10.1016/j.clim.2023.109457

Gordon SF, Sawmy EV, Duckworth E, Wolthuizen M, Clothier HJ, Chea M, Tenneti N, Blow N, Buttery JP, de Luca J, Korman TM, Barnes S, Slade C, Maggs C, Giles ML, Teh BW, Aboltins C, Langan KM, Van Diemen A, Crawford NW. Victorian Specialist Immunisation Services (VicSIS) – bolstering adult clinics for COVID-19 vaccines. Human Vaccines & Immunotherapeutics. 2022;18(5):10.1080/21645515.2022.2052701

De Luca JF, Mackay GA, Chatelier JW, Chan SS, Zhang SS, Godsell J, Spriggs K, Slade C, Douglass JA. Goat milk skin products may cause the development of goat milk allergy. Clinical & Experimental Allergy. 2022;52(5):10.1111/cea.14133

Interested in supporting our research?

Your support will help WEHI’s researchers make discoveries and find treatments to ensure healthier, longer lives for you and your loved ones.

Contact our friendly team to find out how you can help.